Evidence map›Paper›PMID 26492036›Full record

ArticlePloS one2015

Biomarkers of Endothelial Activation Are Associated with Poor Outcome in Critical Illness.

Carmen Mikacenic, William O Hahn, Brenda L Price, Susanna Harju-Baker, Ronit Katz, Kevin C Kain, Jonathan Himmelfarb, W Conrad Liles, Mark M Wurfel

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 2 pooled it
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 2 syntheses or guidelines pooled it, 120 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Observational
  8. Early Dysregulation of Angiopoietin-1 and -2 as a Predictor of Mortality in Critically Ill Burn Patients.Journal of burn care & research : official publication of the American Burn Association · 2026
    Article
  9. Review
  10. Article
  11. Macrophage activation syndrome in Sepsis: from pathogenesis to clinical management.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024
    Review
  12. Observational
  13. Article
  14. Whole blood ratio ofFrontiers in medicine · 2024
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Carmen MikacenicDepartment of Medicine, Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, Washington, United States of America.
William O HahnDepartment of Medicine, Division of Infectious Diseases, University of Washington, Seattle, Washington, United States of America.
Brenda L PriceDepartment of Biostatistics, University of Washington, Seattle, Washington, United States of America.
Susanna Harju-BakerDepartment of Medicine, Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, Washington, United States of America.
Ronit KatzKidney Research Institute, University of Washington, Seattle, Washington, United States of America.
Kevin C KainDepartment of Medicine, Sandra Rotman Centre for Global Health, University Health Network-Toronto General Hospital and the Tropical Disease Unit, University of Toronto, Toronto, Ontario, Canada.
Jonathan HimmelfarbKidney Research Institute, University of Washington, Seattle, Washington, United States of America.
W Conrad LilesDepartment of Medicine, Division of Infectious Diseases, University of Washington, Seattle, Washington, United States of America.
Mark M WurfelDepartment of Medicine, Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, Washington, United States of America.
University of Washington · USUniversity Health Network · CA

Funding

HOST DEFENSE TRAINING IN ALLERGY AND INFECTIOUS DISEASEST32AI007044 · NIAID · UNIVERSITY OF WASHINGTON · PI DAVID Neal FREDRICKS · 1985 to 2026
$14.6M
Influence of TLR1 Polymorphisms on T-Regulatory Cells in ARDSK23HL120896 · NHLBI · UNIVERSITY OF WASHINGTON · PI MIKACENIC, CARMEN R · 2014 to 2018
$881k
NHLBI NIH HHS K23 HL120896NHLBI NIH HHS K23HL120896NIAID NIH HHS T32 AI007044NIAID NIH HHS T32AI007044-39
6 · The paper itself

Abstract

backgroundEndothelial activation plays a role in organ dysfunction in the systemic inflammatory response syndrome (SIRS). Angiopoietin-1 (Ang-1) promotes vascular quiescence while angiopoietin-2 (Ang-2) mediates microvascular leak. Circulating levels of Ang-1 and Ang-2 in patients with SIRS could provide insight on risks for organ dysfunction and death distinct from inflammatory proteins. In this study, we determined if biomarkers of endothelial activation and inflammation exhibit independent associations with poor outcomes in SIRS.

methodsWe studied 943 critically ill patients with SIRS admitted to an Intensive Care Unit (ICU) of an academic medical center. We measured plasma levels of endothelial markers (Ang-1, Ang-2, soluble vascular cell adhesion molecule-1 (sVCAM-1)) and inflammatory markers (interleukin-6 (IL-6), interleukin-8 (IL-8), granulocyte-colony stimulating factor (G-CSF), soluble tumor necrosis factor receptor-1 (sTNFR-1)) within 24 hours of enrollment. We tested for associations between each marker and 28 day mortality, shock, and day 3 sequential organ failure assessment (SOFA) score. For 28 day mortality, we performed sensitivity analysis for those subjects with sepsis and those with sterile inflammation. We used multivariate models to adjust for clinical covariates and determine if associations identified with endothelial activation markers were independent of those observed with inflammatory markers.

resultsHigher levels of all biomarkers were associated with increased 28 day mortality except levels of Ang-1 which were associated with lower mortality. After adjustment for comorbidities and sTNFR-1 concentration, a doubling of Ang-1 concentration was associated with lower 28 day mortality (Odds ratio (OR) = 0.81; p<0.01), shock (OR = 0.82; p<0.001), and SOFA score (β = -0.50; p<0.001), while Ang-2 concentration was associated with increased mortality (OR = 1.55; p<0.001), shock (OR = 1.51; p<0.001), and SOFA score (β = +0.63; p<0.001). sVCAM-1 was not independently associated with SIRS outcomes.

conclusionsIn critically ill patients with SIRS, early measurements of Ang-1 and Ang-2 are associated with death and organ dysfunction independently of simultaneously-measured markers of inflammation.

Indexed as

BiomarkersCohort StudiesCritical IllnessEndothelium, VascularFemaleHumansMaleMiddle AgedMultiple Organ FailureOrgan Dysfunction ScoresPrognosisSurvival RateSystemic Inflammatory Response SyndromeBiomarkers

Identifiers

PMID26492036
PMCPMC4619633
OpenAlexW2165798163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.